EBS Chart
- 52-Week Range: $27.97 - $66.05
- Market Capitalization: $1.44B
- Short Percentage: 0%
- Target Price: $44.33
- Shares Outstanding: 50.24M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
EBS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | April 28th
- Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 24th
- Emergent BioSolutions: Still A Bargain Regardless Of Diminished Growth ForecastsSeeking Alpha | February 13th
Company Info
Website: https://www.emergentbiosolutions.com
Address: 400 Professional Drive, Gaithersburg, MD, United States, 20879
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 2,416
Address: 400 Professional Drive, Gaithersburg, MD, United States, 20879
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 2,416
$EBS who here can't stand the CEO?
$EBS Shorts talk the talk but cant walk the walk
$EBS come on bulls we can do it
don’t let bears win
$EBS HERE WE GO
$EBS you wanna be a successful trader close your trades green
$EBS bull flag
breakout!
$EBS what happens?
$EBS overvalued
$EBS can’t wait to get in this tomorrow lfg
$EBS we had no volume for days before the last big rip